Literature DB >> 31262377

Peanuta non grata.

Joseph A Bellanti, Russell A Settipane.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 31262377      PMCID: PMC6609890          DOI: 10.2500/aap.2019.40.4232

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


× No keyword cloud information.
  23 in total

1.  Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema.

Authors:  James Fox; Arthur B Vegh; Inmaculada Martinez-Saguer; Walter A Wuillemin; Jonathan Edelman; Debora Williams-Herman; Mikhail Rojavin; Tanja Rosenberg
Journal:  Allergy Asthma Proc       Date:  2017-05-01       Impact factor: 2.587

2.  Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase.

Authors:  Karsten Weller; Marcus Maurer; Moshe Fridman; Dylan Supina; Jennifer Schranz; Markus Magerl
Journal:  Allergy Asthma Proc       Date:  2017-01-16       Impact factor: 2.587

3.  Current management and use of oral immunotherapy in the United States for patients with peanut allergy.

Authors:  Michael S Blaiss; Stephen Tilles; Daniel Petroni; Ellen Zigmont; Marie Cassese; Brian Kwak; Nicholas Georgitseas; Jay Liebermann
Journal:  Allergy Asthma Proc       Date:  2019-05-23       Impact factor: 2.587

Review 4.  New and evolving therapies for hereditary angioedema.

Authors:  Sara Barmettler; Yu Li; Aleena Banerji
Journal:  Allergy Asthma Proc       Date:  2019-01-01       Impact factor: 2.587

5.  Hereditary angioneurotic edema … a disease has been described.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2017-11-01       Impact factor: 2.587

6.  Health-related quality of life in Danish children with hereditary angioedema.

Authors:  Anne Aabom; Dan Nguyen; Niels Fisker; Anette Bygum
Journal:  Allergy Asthma Proc       Date:  2017-11-01       Impact factor: 2.587

7.  Assessment on hereditary angioedema burden of illness in Brazil: A patient perspective.

Authors:  Anderson Abdon Barbosa; Raquel de Oliveira Martins; Renata Martins; Anete Sevciovic Grumach
Journal:  Allergy Asthma Proc       Date:  2019-05-01       Impact factor: 2.587

8.  Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.

Authors:  Frank C Hampel; Andrew J Pedinoff; Robert L Jacobs; Cynthia F Caracta; Sudeesh K Tantry
Journal:  Allergy Asthma Proc       Date:  2019-05-03       Impact factor: 2.587

9.  Health-related quality of life in relation to disease activity in adults with hereditary angioedema in Sweden.

Authors:  Patrik Nordenfelt; Mats Nilsson; Anders Lindfors; Carl-Fredrik Wahlgren; Janne Björkander
Journal:  Allergy Asthma Proc       Date:  2017-08-30       Impact factor: 2.587

10.  Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial.

Authors:  H Henry Li; Sarah Mycroft; Sandra Christiansen; Daniel N Wood; Henrike Feuersenger; Dipti Pawaskar; Iris Jacobs
Journal:  Allergy Asthma Proc       Date:  2018-08-14       Impact factor: 2.587

View more
  1 in total

1.  Peanuta non grata revisited.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2019-09-01       Impact factor: 2.587

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.